4D Pharma (DDDD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 95.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 190.00
  • 52 Week Low: 81.00
  • Currency: UK Pounds
  • Shares Issued: 65.49m
  • Volume: 2,481
  • Market Cap: 62.22m
  • Beta: 0.01

4D Pharma Overview

4D Pharma is in the pharma and biotech sector and is currently trading at 95.00p per share. In the last year 4D Pharma 's share price has ranged from 81.00p to 190.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 1.4  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

4D Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 n/a (2.38) (4.81)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (10.06) (12.62)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (11.71) (15.21)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (23.99) (26.08)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (28.44) (36.17)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

4D Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a n/a (41.10)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a n/a (40.60)p n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

4D Pharma Company Announcements

Holding(s) in Company 08-Jul-2019 15:51 RNS
Change of Adviser 01-Jul-2019 07:00 RNS
Result of AGM 20-Jun-2019 10:38 RNS

Latest 4D Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

4D Pharma Market Data

Currency UK Pounds
Share Price 95.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 190.00
52 Week Low 81.00
Volume 2,481
Shares Issued 65.49m
Market Cap 62.22m
Beta 0.01

4D Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.05% below the market average6.05% below the market average6.05% below the market average6.05% below the market average6.05% below the market average
1.69% below the sector average1.69% below the sector average1.69% below the sector average1.69% below the sector average1.69% below the sector average
Price Trend
73.04% below the market average73.04% below the market average73.04% below the market average73.04% below the market average73.04% below the market average
57.38% below the sector average57.38% below the sector average57.38% below the sector average57.38% below the sector average57.38% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

4D Pharma Dividends

No dividends found

Trades for 19-Jul-2019

Time Volume / Share Price
11:11 378 @ 93.95p
09:42 103 @ 95.42p
09:15 2,000 @ 93.95p

4D Pharma Key Personnel

CEO Duncan Joseph Peyton

Top of Page